Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

December 21, 2023

https://www.globenewswire.com/news-release/2023/12/21/2800165/0/en/Marker-Therapeutics-Announces-Participation-in-Biotech-Showcase-and-the-19th-Annual-Non-Dilutive-Funding-Summit-During-J-P-Morgan-Week-2024.html

HOUSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, announced today that the Company’s management team will participate in Biotech Showcase and present at the 19th Annual Non-Dilutive Funding Summit. Both events will be held in-person and are scheduled alongside the J.P. Morgan 42nd Annual Healthcare Conference 2024.

Read more at globenewswire.com

Related news for (MRKR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.